Recombinant Human MGST1 Protein，His

MGST1 (microsomal glutathione S-transferase 1) is a key enzyme involved in the detoxification of harmful compounds and the metabolism of various xenobiotics in the human body. Its primary function is to catalyze the conjugation of glutathione, a powerful antioxidant, to electrophilic substrates, which facilitates their excretion and reduces oxidative stress. Research on MGST1 has gained significance due to its implications in drug metabolism, cancer biology, and various diseases linked to oxidative stress, such as neurodegenerative disorders and cardiovascular diseases. Moreover, alterations in MGST1 expression have been associated with drug resistance in cancer therapy, highlighting its potential as a therapeutic target. The recombinant production of MGST1 protein enables researchers to investigate its biochemical properties, structural characteristics, and functional mechanisms in detail. By employing techniques such as site-directed mutagenesis and crystal structure analysis, scientists aim to uncover the structure-activity relationship (SAR) of MGST1 and identify potential inhibitors or activators that could modulate its activity. This research holds promise for developing novel pharmacological strategies to enhance detoxification pathways and combat diseases associated with oxidative damage, ultimately contributing to improved health outcomes and targeted therapies in clinical settings.